Antibody purification

Antibody purification

  • CN 102,391,358 B
  • Filed: 04/04/2007
  • Issued: 08/10/2016
  • Est. Priority Date: 04/05/2006
  • Status: Active Grant
First Claim
Patent Images

1. a pharmaceutical composition, described pharmaceutical composition comprises adalimumab and drug acceptable carrier, wherein said groupCompound has the cathepsin L activity less than 1.84RFU/s/mg adalimumab, and wherein said adalimumab is by feedingBreast gene expressive system of animals produces.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×